Loading
collectionsCollection
SEER (Surveillance, Epidemiology, and End Results)
SEER records how many people in the US get each cancer and how long they live, by stage, age, race, and year.
Overview
SEER, the Surveillance, Epidemiology, and End Results programme, holds US cancer incidence, survival and prevalence statistics collected since 1973, broken down by stage, age, race and year of diagnosis. It is run by the NCI and the statistics are public; SEER*Explorer provides interactive access, and the data underpin most published US survival figures. On OnCo it is cited by the bottlenecks The hardest cancers are found late, Survivorship and late effects are neglected, Data silos, Weak real-world evidence and registries and Funding follows fashion, not burden. It also supports ideas such as A live national dashboard of stage at diagnosis as the scorecard for early detection and Randomise inside the cancer registry: registry-based trials for everyday questions.
Holds
US cancer incidence, survival, and prevalence statistics since 1973.
Licence
Public
Maintainer
NCI
Similar pages
- CollectionGLOBOCAN / Global Cancer Observatory
Shares A public tracker of how long each country takes to adopt new evidence, A public dashboard of research money per death for every cancer, Make a population cancer registry a condition of every cancer aid programme, Set trial enrolment targets from who actually gets the disease, and publish progress live.
- CollectionAACR Project GENIE
Shares Emulate the trial in real-world data first to decide which trials to run, Link every national cancer registry to tumour genomics, An organotropism atlas that predicts where a cancer will spread, Randomise inside the registry that already follows every patient.
- IdeaMandatory machine-readable portfolio reporting for all large cancer funders
Shares A public dashboard of research money per death for every cancer, Data silos, Funding follows fashion, not burden, National Cancer Institute (NIH).
- IdeaEnrol every new systemic therapy into a registry linkage that will still report in thirty years
Shares A national late-effects registry linking treatment exposures to outcomes decades later, Registries count diagnoses and deaths, and not what treatment left behind, Weak real-world evidence and registries, Data silos.
- CollectionPanCareSurFup and the European survivor cohorts
Shares Counting the people who live after cancer, and why the number is not a detail, Registries count diagnoses and deaths, and not what treatment left behind, Data silos, Survivorship and late effects are neglected.
- CollectionClinicalTrials.gov
Shares Set trial enrolment targets from who actually gets the disease, and publish progress live, A public map of trial deserts to steer where new sites open, Pay for residual disease tests only inside a trial or registry, Randomise inside the registry that already follows every patient.
- CollectioncBioPortal for Cancer Genomics
Shares Bank yearly blood from cancer survivors so future tests can be validated, An organotropism atlas that predicts where a cancer will spread, Data silos.
- TermReal-world evidence
Shares Automatic weekly linkage of cancer registries to deaths, prescriptions and imaging, Emulate the trial in real-world data first to decide which trials to run, Randomise inside the cancer registry: registry-based trials for everyday questions, Mandatory interval-cancer audit for every blood-based screening test.
cancers
technologies
institutions
terms
ideas
A live national dashboard of stage at diagnosis as the scorecard for early detectionA national late-effects registry linking treatment exposures to outcomes decades laterA public dashboard of research money per death for every cancerA public map of trial deserts to steer where new sites openA public tracker of how long each country takes to adopt new evidenceAn organotropism atlas that predicts where a cancer will spreadAutomatic weekly linkage of cancer registries to deaths, prescriptions and imagingBank yearly blood from cancer survivors so future tests can be validatedCheap long-term survival follow-up by linking trial participants to registriesEmulate the trial in real-world data first to decide which trials to runLink every national cancer registry to tumour genomicsMake a population cancer registry a condition of every cancer aid programmeMandatory interval-cancer audit for every blood-based screening testPay for residual disease tests only inside a trial or registryRandomise inside the cancer registry: registry-based trials for everyday questionsRandomise inside the registry that already follows every patientRecord and publish the symptom-to-diagnosis interval for every cancer, by hospitalSet trial enrolment targets from who actually gets the disease, and publish progress live
collections
bottlenecks
journals
Open-source projects
All open source in oncology →Open-source projects that are the code behind this collection or publish it, from OnCo's own catalogue: licence and last activity as the repository reported them on the day of the fetch. Listing is not endorsement; check the licence before reuse and the validation before clinical use.
The reference Java library for the NAACCR XML data exchange standard used by North American cancer registries.
Java implementations of the algorithms SEER registries apply: site recodes, survival time, census tract linkage and more.